News

Begin thinking of your business as a 'disease' company vs. a 'drug' company

Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.

National organization proposes a draft standard; will hold workship in May

Analytics based on returns data can be a marketing tool for manufacturers

Former OTC head, known for her marketing expertise, is out the door

Federal judge lifts temporary restraining order against DEA; action now moves to DEA administrative judge

Federal judge lifts temporary restraining order against DEA; action now moves to DEA administrative judge

Buys marketing rights to networks of independent pharmacies for C$920 million

Bilcare Research brings multiphase stability and shelf-life testing to drug developers as a step to choosing the right blister-card materials

Announces more contract wins; integration with other software platforms in sales force automation

Program adds a one-day seminar on business continuity planning

While 'data mining' is the catchphrase of the moment for business analytics, some pharma companies are finding value in mining their channel data assets

The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future

OHL pays a $1-million fine for misreporting TSA inspections; Envirotainer is bollixed by FAA

Health authorities in the US and Europe are chasing down counterfeit sources

Avastin scandal throws a spotlight on trade-activity monitoring

NanoGuardian’s NanoEncryption technology wins a multiyear agreement with top-10 manufacturer

FDA believes that the fakes were obtained from an offshore distributor, supplying another distributor in Tennessee; Genentech confirms fakes contain no active ingredient

Acquisition continues growth of data mining into product marketing and pricing

Federal judge asks DEA for show cause information; DEA claims millions of suspicious orders

Meanwhile, World Courier remains up for bid, possibly to be acquired by FedEx

Buyout expands Walgreens specialty-pharmacy patient base by 500,000

CEO George Barrett aggressively protests DEA suspension of the operating license of the company's Lakeland, FL, facility, and the company wins a temporary restraining order against the suspension

An estimated 30 packages of birth-control pills causes a recall of over 1 million, according to the WSJ

Will represent industry's interests to pan-European governments and regulators

But will anti-terrorism concerns trump commercial interests?

Armada Health Care streamlines prior auth with free ApproveRx service

New guidelines prepare for eventual item-level serialization, while embodying FDA guidance for barcoded hospital-supply products